Outcome Study of Lanthanum Carbonate Compared With Calcium Carbonate in Hemodialysis Patients : Landmark Study

NCT01578200 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2309

Enrollment

OTHER

Sponsor class

Conditions

Hemodialysis
Hyperphosphatemia

Interventions

DRUG: Lanthanum Carbonate
DRUG: Calcium Carbonate

Sponsor

Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan

Collaborators

[object Object]